June 27, 2013in Infringement, IP, Jurisdiction, Patent Practice, Patents, Pharmaceutical Drugs, Regulatory Policy, Reputation Management, US0by Editor162 Splitting the Difference Between Antitrust and Intellectual Property: FTC v Actavis The dividing line between intellectual property and antitrust laws was further clarified last week when the Supreme Court of the United States (SCOTUS) settled a debate on the illegality of…
